Prevalence and predictors of anti-infective use during pregnancy

Pharmacoepidemiology and Drug Safety

Volumn 19, Issue 4, 2010, Pages 418-427

  Santos, Fabiano ^a,b   Oraichi, Driss ^a,b   Bérard, Anick ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CEPHALOSPORIN; LINCOSAMIDE; MACROLIDE; PENICILLIN G; QUINOLONE; STREPTOGRAMIN; SULFONAMIDE; TETRACYCLINE;

ARTICLE; CANADA; COHORT ANALYSIS; COMPARATIVE STUDY; DATA BASE; DRUG UTILIZATION; EXPOSURE; FEMALE; GESTATIONAL AGE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PERINATAL PERIOD; PREGNANCY; PRENATAL PERIOD; PREVALENCE; PRIORITY JOURNAL; REGISTRATION; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS; COHORT STUDIES; DRUG UTILIZATION REVIEW; FEMALE; HUMANS; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS; PREVALENCE; PROGNOSIS; QUEBEC; REGISTRIES; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77950906047     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1915     Document Type: Article

References (35)

1. Amann U, Egen-Lappe V, Strunz-Lehner C, Hasford J. Antibiotics in pregnancy: analysis of potential risks and determinants in a large German statutory sickness fund population. Pharmacoepidemiol Drug Saf 2006; 15: 327-337. (Pubitemid 43797120)
2. Dashe JS, Gilstrap LC III. Antibiotic use in pregnancy. Obstet Gynecol Clin North Am 1997; 24: 617-629.
3. Guidelines. Antimicrobial Therapy - A Concise Canadian Guide 2007. Montreal: Prism, 2007.
4. Norwitz ER, Greenberg JA. Antibiotics in pregnancy: are they safe? Rev Obstet Gynecol 2009; 2: 135-136.
5. Sa del FF, Gerenutti M, Groppo FC. Antibiotics and pregnancy. Pharmazie 2005; 60: 483-493.
6. Loebstein R, Addis A, Ho E, Andreou R, Sage S, Donnenfeld AE, et al., Pregnancy outcome following gestational exposure to fluoroquinolones: a multicenter prospective controlled study. Antimicrob Agents Chemother 1998; 42: 1336-1339. (Pubitemid 28257627)
7. Bar-Oz B, av-Citrin O, Shechtman S, Tellem R, Arnon J, Francetic I, et al., Pregnancy outcome after gestational exposure to the new macrolides: a prospective multi-center observational study. Eur J Obstet Gynecol Reprod Biol 2008; 141: 31-34.
8. Sarkar M, Woodland C, Koren G, Einarson AR. Pregnancy outcome following gestational exposure to azithromycin. BMC Pregnancy Childbirth 2006; 6: 18. (Pubitemid 43950611)
9. Gendron MP, Martin B, Oraichi D, Berard A. Health care providers' requests to Teratogen Information Services on medication use during pregnancy and lactation. Eur J Clin Pharmacol 2009; 65: 523-531.
10. World Health Organization. International Classification of Diseases. 1997.
11. Régie de l'assurance maladie du Québec: Statistiques annuelles. Goverment of Quebec. 1997.
12. Berard A, Lacasse A. Validity of perinatal pharmacoepidemiologic studies using data from the RAMQ administrative database. Can J Clin Pharmacol 2009; 16(2): e360-e369.
13. Tamblyn R, Lavoie G, Petrella L, Monette J. The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Quebec. J Clin Epidemiol 1995; 48: 999-1009.
14. Vilain A, Otis S, Forget A, Blais L. Agreement between administrative databases and medical charts for pregnancy-related variables among asthmatic women. Pharmacoepidemiol Drug Saf 2008; 17: 345-353. (Pubitemid 351566350)
15. Levy AR, Mayo NE, Grimard G. Rates of transcervical and pertrochanteric hip fractures in the province of Quebec, Canada, 1981-1992. Am J Epidemiol 1995; 142: 428-436.
16. Blais L, Desgagne A, LeLorier J. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case-control study. Arch Intern Med 2000; 160: 2363-2368.
17. Garbe E, LeLorier J, Boivin JF, Suissa S. Risk of ocular hypertension or open-angle glaucoma in elderly patients on oral glucocorticoids. Lancet 1997; 350: 979-982. (Pubitemid 27421106)
18. Avorn J, Monette J, Lacour A, Bohn RL, Monane M, Mogun H, et al., Persistence of use of lipid-lowering medications: a cross-national study. JAMA 1998; 279: 1458-1462. (Pubitemid 28228203)
19. Ramos E, Oraichi D, Rey E, Blais L, Berard A. Prevalence and predictors of antidepressant use in a cohort of pregnant women. BJOG 2007; 114: 1055-1064. (Pubitemid 47247022)
20. Berard A, Azoulay L, Koren G, Blais L, Perreault S, Oraichi D. Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective. Br J Clin Pharmacol 2007; 63: 196-205. (Pubitemid 46072106)
21. WHO Collaborating Centre for Drug Statistics Methodology. WHO Collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/ atcddd/ (accessed 5 December 2008).
22. Czeizel AE, Rockenbauer M, Olsen J. Use of antibiotics during pregnancy. Eur J Obstet Gynecol Reprod Biol 1998; 81: 1-8.
23. Olesen C, Steffensen FH, Nielsen GL, de Jong-van den Berg L, Olsen J, Sorensen HT. Drug use in first pregnancy and lactation: a population-based survey among Danish women. The EUROMAP group. Eur J Clin Pharmacol 1999; 55: 139-144. (Pubitemid 29196267)
24. Henry A, Crowther C. Patterns of medication use during and prior to pregnancy: the MAP study. Aust NZ J Obstet Gynaecol 2000; 40: 165-172. (Pubitemid 30323587)
25. Splinter MY, Sagraves R, Nightengale B, Rayburn WF. Prenatal use of medications by women giving birth at a university hospital. South Med J 1997; 90: 498-502. (Pubitemid 27376945)
26. Chamany S, Schulkin J, Rose CE, Jr., Riley LE, Besser RE. Knowledge, attitudes, and reported practices among obstetrician-gynecologists in the USA regarding antibiotic prescribing for upper respiratory tract infections. Infect Dis Obstet Gynecol 2005; 13: 17-24. (Pubitemid 40676983)
27. Schanzer DL, Langley JM, Tam TW. Influenza-attributed hospitalization rates among pregnant women in Canada 1994-2000. J Obstet Gynaecol Can 2007; 29: 622-629.
28. Jamieson DJ, Theiler RN, Rasmussen SA. Emerging infections and pregnancy. Emerg Infect Dis 2006; 12: 1638-1643.
29. Wise R. Prescribing in pregnancy. Br Med J 1987.
30. Macejko AM, Schaeffer AJ. Asymptomatic bacteriuria and symptomatic urinary tract infections during pregnancy. Urol Clin North Am 2007; 34: 35-42. (Pubitemid 44834540)
31. Andriole VT, Patterson TF. Epidemiology, natural history, and management of urinary tract infections in pregnancy. Med Clin North Am 1991; 75: 359-373.
32. Sexually Transmitted Diseases in Canada: 1996 Surveillance Report. Health Canada. Government of Canada, 1997.
33. Koren G, MacLeod S, Davis D. Drugs in pregnancy: acknowledging challenges - finding solutions. Can J Clin Pharmacol 2007; 14: e2-e4. (Pubitemid 46198379)
34. Zenclussen AC, Schumacher A, Zenclussen ML, Wafula P, Volk HD. Immunology of pregnancy: cellular mechanisms allowing fetal survival within the maternal uterus. Expert Rev Mol Med 2007; 294: 42-46.
35. Le BP, Tabiasco J. Immunology of pregnancy: renewed interest. Med. Sci. (Paris) 2006; 22: 745-750.